Induction with ribavirin in a relapsing patient with chronic HCV hepatitis

Induction with ribavirin in a relapsing patient with chronic HCV hepatitis

Show other versions (1)

In this case, a new possible strategy for treatment of hepatitis C virus (HCV) relapsing patients is described. The target of anti-HCV therapy is sustained viral response, but strategies for improving sustained viral response in relapsing patients would be useful, and ribavirin is crucial for obtain...

Full description

Bibliographic Details
Main Authors:	Claudio Ucciferri, Paola Mancino, Francesca Vignale, Jacopo Vecchiet, Katia Falasca
Format:	Article
Language:	English
Published:	Elsevier
Series:	Brazilian Journal of Infectious Diseases
Subjects:	induction re-treatment sustained viral response hepatitis C virus
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702012000300015&lng=en&tlng=en

Similar Items

Induction with ribavirin in a relapsing patient with chronic HCV hepatitis
by: Claudio Ucciferri, et al.
Published: (2012-05-01)

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Paola Mancino, et al.
Published: (2010-03-01)

USE OF HEMATOPOIETIC GROWTH FACTOR IN THE MANAGEMENT OF HEMATOLOGICAL SIDE EFFECTS ASSOCIATED TO ANTIVIRAL TREATMENT FOR HCV HEPATITIS
by: Claudio Ucciferri, et al.
Published: (2010-02-01)

Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin
by: Guillermo Cabrera Álvarez, et al.
Published: (2011-10-01)

Cystatin C and cardiovascular risk in HIV infected patients
by: Vecchiet Jacopo, et al.
Published: (2010-05-01)

Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin
by: Sebastien Lhomme, et al.
Published: (2019-07-01)

Hepatitis C III. Estudio laparoscópico, histológico y niveles séricos de alanina aminotransferasa en 160 pacientes seropositivos al virus de la hepatitis C Hepatitis C III. Laparoscopic and histological study and serum levels of alanine aminotransferase in 160 HCV seropositive patients
by: Jorge Valdés Moreno, et al.
Published: (2005-03-01)

Cardiac toxicity associated with HCV direct antiviral agents
by: Claudio Ucciferri, et al.
Published: (2018-10-01)

Association of baseline CD4+ cell count and HIV-RNA on sustained virologic response to interferon-ribavirin in HIV/HCV coinfected patients
by: Teresa Aldámiz-Echevarría, et al.
Published: (2015-07-01)

Hepatitis C I: Frecuencia de seropositivos al VHC en los diferentes servicios del Hospital “Calixto García” en el trienio 1996-1998 Hepatitis C I. Frequency of HCV-seropositive patients at different services of “Calixto García”Hospital from 1996 to l998
by: Jorge Valdés Moreno, et al.
Published: (2004-12-01)

Hepatitis C II: Principales vías de transmisión e influencia de la edad y el sexo en la infección por el virus de la hepatitis C en 160 pacientes seropositivos Hepatitis C II. Main routes of transmission and influence of sex and age on HCV in 160 seropositive cases
by: Jorge Valdés Moreno, et al.
Published: (2004-12-01)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
by: Stephanie Popping, et al.
Published: (2019-01-01)

Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials
by: Donald M. Jensen, et al.
Published: (2016-05-01)

Peripheral blood correlates of virologic relapse after Sofosbuvir and Ribavirin treatment of Genotype-1 HCV infection
by: Cody Orr, et al.
Published: (2020-12-01)

Quantitation of HCV RNA in liver of patients with chronic hepatitis C Quantificação do RNA-HCV no fígado de pacientes com hepatite C crônica
by: Ana de Lôurdes Candolo MARTINELLI, et al.
Published: (2000-10-01)

Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial
by: Mario G. Pessôa, et al.
Published: (2012-01-01)

Late-Relapsing Hepatitis after Yellow Fever
by: Izabela Maurício Rezende, et al.
Published: (2020-02-01)

Fibromyalgia syndrome in chronic hepatitis C virus (HCV) infection patients: A potential association and pathogenic role
by: Abdel Moatty A. Afifi, et al.
Published: (2022-01-01)

Identification of the Intragenomic Promoter Controlling Hepatitis E Virus Subgenomic RNA Transcription
by: Qiang Ding, et al.
Published: (2018-05-01)

Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries
by: A. M. Falla, et al.
Published: (2018-01-01)

Actualización sobre hepatitis viral: etiología, patogenia, diagnóstico microbiológico y prevención
by: Carmen Rodríguez Acosta
Published: (2000-12-01)

CD81 and Hepatitis C Virus (HCV) Infection
by: Lucie Fénéant, et al.
Published: (2014-02-01)

A Comparison of Interferon-Alpha-2b Induction Therapy with Interferon-Alpha-2b Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C
by: Bilgehan AYGEN, et al.
Published: (2004-09-01)

Permissiveness of human hepatoma cell lines for HCV infection
by: Sainz Bruno, et al.
Published: (2012-01-01)

Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design
by: Florian Wrensch, et al.
Published: (2018-06-01)

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study
by: Javier Milara, et al.
Published: (2015-01-01)

Ribavirin in acute viral hepatitis.
by: Tilve G, et al.
Published: (1991-07-01)

Hepatitis E virus: A leading cause of waterborne viral hepatitis in Northwest Districts of Punjab, India
by: Maninder Kaur, et al.
Published: (2017-04-01)

A Study of Seroprevalence and Co-infection of Hepatitis A and Hepatitis E Viruses in Sporadic Cases in an Endemic Area
by: Monika Agrawal, et al.
Published: (2016-10-01)

Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy
by: Claudio Ucciferri, et al.
Published: (2016-07-01)

Long term effect of telmisartan in HIV-positive male patients with high blood pressure
by: Claudio Ucciferri, et al.
Published: (2015-11-01)

Hepatitis E virus incidence in patients with non-identified acute viral hepatitis in Mexico
by: R. Berebichez-Fridman, et al.
Published: (2016-07-01)

Human Herpesviruses Increase the Severity of Hepatitis
by: Kirill I. Yurlov, et al.
Published: (2021-05-01)

Molecular characterization of the hepatitis B virus X gene
by: Malinga, Lesibana Anthony
Published: (2012)

CHRONIC VIRAL HEPATITIS В AND C IN CHILDREN BORN FROM MOTHERS INFECTED WITH НВV AND HCV
by: T. I. Raba
Published: (2017-03-01)

Two Cases of Travel-Related Acute Hepatitis E
by: Can Hüseyin HEKİMOĞLU, et al.
Published: (2013-03-01)

El ABC de las hepatitis virales ¿Ahora de la A a la G? Tha ABC of viral hepatitis: now from A to G?
by: Jaime Leyva Tejada
Published: (1992-02-01)

Hepatitis C Direct Acting Antivirals and Ribavirin Modify Lipid but not Glucose Parameters
by: Mary-Anne Doyle, et al.
Published: (2019-03-01)

Hepatitis E: Genotypes, strategies to prevent and manage, and the existing knowledge gaps
by: Lubna Kamani, et al.
Published: (2021-10-01)

Effect of HLA on hepatitis C virus clearance and persistence in anti-HCV-positive end-stage renal disease patients
by: Serkan Ocal, et al.
Published: (2014-01-01)